Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SPHERE Per-AF Post-Approval Study

NCT: NCT06858306 · ACTIVE_NOT_RECRUITING

NCT IDNCT06858306
StatusACTIVE_NOT_RECRUITING
Start Date2025-09-25
SponsorMedtronic Cardiac Ablation Solutions (INDUSTRY)
First posted
Last updated

Brief Summary

SPHERE Per-AF Post-Approval Study is a prospective, multi-center, non-randomized, observational trial. Subjects will be treated with the Sphere-9™ Catheter and Affera™ Ablation System and followed through 36 months.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑